Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

January 2012
1. YANG X , Wang J, Zhou Y, Wang Y, et al
   Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ABU-YOUSIF AO , Moor AC, Zheng X, Savellano MD, et al
   Epidermal Growth Factor Receptor-Targeted Photosensitizer Selectively Inhibits EGFR Signaling and Induces Targeted Phototoxicity In Ovarian Cancer Cells.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GLOSS BS , Samimi G
   Epigenetic Biomarkers in Epithelial Ovarian Cancer.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. GLOSS BS , Patterson KI, Barton CA, Gonzalez M, et al
   Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHAH PP , Kakar SS
   Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.
   Cancer Lett. 2011;311:66-76.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. GEST C , Mirshahi P, Li H, Pritchard LL, et al
   Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ZHOU S , Li Y, Huang F, Zhang B, et al
   Live-attenuated measles virus vaccine confers cell contact loss and apoptosis of ovarian cancer cells via ROS-induced silencing of E-cadherin by methylation.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. LEE KB , Byun HJ, Park SH, Park CY, et al
   CYR61 controls p53 and NF-kappaB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
9. CHEN X , Yan Q, Li S, Zhou L, et al
   Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. THERIAULT BL , Nachtigal MW
    Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFbeta superfamily signalling.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. MANDAI M , Matsumura N, Baba T, Yamaguchi K, et al
    Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
12. SUN H , Yu T, Li J
    Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. TAN D , Chen KE, Khoo T, Walker AM, et al
    Prolactin increases survival and migration of ovarian cancer cells: Importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CHUANG TC , Hsu SC, Cheng YT, Shao WS, et al
    Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SOLAR P , Sytkowski AJ
    Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. COHEN M , Petignat P
    Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
17. PIGNATA S , Cannella L, Leopardo D, Pisano C, et al
    Chemotherapy in epithelial ovarian cancer.
    Cancer Lett. 2011;303:73-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHOI YP , Shim HS, Gao MQ, Kang S, et al
    Molecular portraits of intratumoral heterogeneity in human ovarian cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
19. SU W , Huang L, Ao Q, Zhang Q, et al
    Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1alpha
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SCHULTE RR , Linkous AG, Hallahan DE, Yazlovitskaya EM, et al
    Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
21. ZHANG Y , Wang C, Wang H, Wang K, et al
    Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SUZUKI M , Iwasaki M, Sugio A, Hishiya A, et al
    BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ZHANG Y , Tang H, Cai J, Zhang T, et al
    Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
24. AHMAD N , Kumar R
    Steroid hormone receptors in cancer development: a target for cancer therapeutics.
    Cancer Lett. 2011;300:1-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
25. FANG LQ , Zhang H, Ding XY, Li DQ, et al
    Mouse trophoblastic cells exhibit a dominant invasiveness phenotype over cancer cells.
    Cancer Lett. 2010;299:111-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
26. BASAPPA , Murugan S, Kavitha CV, Purushothaman A, et al
    A small oxazine compound as an anti-tumor agent: a novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-alpha.
    Cancer Lett. 2010;297:231-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ZHU H , Liu XW, Ding WJ, Xu DQ, et al
    Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.
    Cancer Lett. 2010;297:155-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. WANG L , Chen H, Liu F, Madigan MC, et al
    Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
29. MONNIER J , Samson M
    Prokineticins in angiogenesis and cancer.
    Cancer Lett. 2010;296:144-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
30. IYEVLEVA AG , Suspitsin EN, Kroeze K, Gorodnova TV, et al
    Non-founder BRCA1 mutations in Russian breast cancer patients.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
31. ZUCO V , Benedetti V, Zunino F
    ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968.
    Cancer Lett. 2010;292:186-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. LI H , Takai N, Yuge A, Furukawa Y, et al
    Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
33. HELLSTROM I , Heagerty PJ, Swisher EM, Liu P, et al
    Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
34. WANG Y , Niu XL, Qu Y, Wu J, et al
    Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
35. HWANG IY , Baguley BC, Ching LM, Gilchrist CA, et al
    The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HE X , Chen H, Wu D, Cui L, et al
    Tandem-epitope peptide: a novel stimulator for gammadeltaT cells in tumor immunotherapy.
    Cancer Lett. 2010;288:86-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2009
37. CUI SX , Qu XJ, Gao ZH, Zhang YS, et al
    Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
    Cancer Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: